Multiple SclerosisCanadaMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveSclerosisAmyotrophic Lateral SclerosisSocieties, MedicalEncephalomyelitis, Autoimmune, ExperimentalTuberous SclerosisDemyelinating DiseasesOptic NeuritisMagnetic Resonance ImagingMyelin Basic ProteinScleroderma, SystemicBrainOligoclonal BandsInterferon-betaMyelin SheathMyelin-Oligodendrocyte GlycoproteinSpinal CordDisability EvaluationMyelin ProteinsSocietiesOligodendrogliaMyelin-Associated GlycoproteinNeuromyelitis OpticaSocieties, ScientificDisease ProgressionCentral Nervous SystemMyelin Proteolipid ProteinAtrophyImmunologic FactorsHLA-DR2 AntigenEncephalomyelitis, Acute DisseminatedCase-Control StudiesSeverity of Illness IndexOntarioCuprizoneNerve Fibers, MyelinatedDiffuse Cerebral Sclerosis of SchilderPropylene GlycolsDisease Models, AnimalDemyelinating Autoimmune Diseases, CNSNervous System DiseasesRecurrenceTheilovirusAxonsTime FactorsAge of OnsetCerebrospinal FluidT-LymphocytesHLA-DRB1 ChainsBritish ColumbiaCerebrospinal Fluid ProteinsMicrogliaTreatment OutcomeOptic NerveFollow-Up StudiesAutoimmune DiseasesNeurologic ExaminationCardiovirus InfectionsFatigueRemission, SpontaneousAutoimmunityMice, Inbred C57BLCohort StudiesImmunosuppressive AgentsReproducibility of ResultsBlood-Brain BarrierMethylprednisoloneAstrocytesEvoked Potentials, VisualAutoantibodiesGenetic Predisposition to DiseaseImmunoglobulin GRetrospective StudiesScleroderma, DiffuseSocieties, NursingAlbertaDisabled PersonsRisk FactorsHLA-DR AntigensStatistics, NonparametricQuebecGadoliniumQuestionnairesInflammationProspective StudiesNeuritisAutoantigensCentral Nervous System DiseasesNerve DegenerationMyelitis, TransverseImage EnhancementCells, CulturedSensitivity and SpecificityBiological MarkersCorpus CallosumAdjuvants, ImmunologicCytokines